<DOC>
	<DOC>NCT01209364</DOC>
	<brief_summary>The primary objective is to determine whether Durolane is non-inferior to methylprednisolone, as assessed by level of pain, when each are given as single intra-articular injections for the relief of pain, in the treatment of symptomatic osteoarthritis of the knee at 12 weeks.</brief_summary>
	<brief_title>Durolane Versus Methylprednisolone in Knee Osteoarthritis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<criteria>Subject (female or male) 3580 years of age Unilateral knee pain Radiographic evidence of OA WOMAC pain score of 717 Subject normally active Subject has attempted but not responded adequately to previous nonpharmacological therapy(ies); Subject cooperative and able to communicate effectively with the investigators; Body mass index â‰¤ 40 kg/m2; Signed informed consent obtained. Knee effusion Contralateral knee OA Clinically significant joint pain from joints other than the knee Previous intraarticular steroid injection into the study knee within the last 3 months; Previous intraarticular HA injection into the study knee within the last 9 months; Previous allergic type reaction to a HA product, a steroid, or lidocaine/related anesthetics; Treatment with analgesics other than paracetamol (acetaminophen) (including topical agents for the knee) within 5 half lives of the drug prior to the baseline visit; Use of systemic glucocorticosteroids (excluding inhaled steroids) within the last 3 months; Treatment with glucosamine/chondroitin sulfate initiated within the past 3 months Change in physical therapy for the knee within the last three months Arthroscopy or other surgical procedure in the study knee within the past 12 months; Any planned arthroscopy or other surgical procedure during the study period; Previous history or presence of active septic arthritis Active skin disease or infection in the area of the injection site; Systemic active inflammatory condition or infection Bleeding diathesis or use of anticoagulants Current uncontrolled diabetes mellitus; Any medical condition that in the opinion of the investigator makes the subject unsuitable for inclusion Pregnant or breastfeeding woman or woman of childbearing potential not practicing adequate contraception; Involvement in other clinical trials</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>comparative</keyword>
	<keyword>randomized</keyword>
	<keyword>double-blind</keyword>
	<keyword>non-inferior</keyword>
	<keyword>knee OA</keyword>
</DOC>